Building Blocks

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>8-Methoxy-6-methylquinolin-4-ol (8MQ) is a mitochondrial substrate that has been shown to have physiological functions in energy metabolism and lysine biosynthesis. 8MQ has been shown to be a potential drug target for the treatment of corynebacterium glutamicum, which produces acid formation. 8MQ also inhibits wild-type strains of bacteria and clinical isolates of HIV. The m2 phenotype is an HIV-1 protein that is essential for viral replication. 8MQ binding to this protein prevents it from binding with other proteins on the surface of the virus, inhibiting its ability to bind with CD4 cells and infect new cells.</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Thienopyridine analogs are a class of chemical compounds that function as agonists of the receptor α. These compounds have been shown to inhibit fatty acid oxidation and ATP production in rat liver cells, which may be due to their ability to activate AMP-activated protein kinase (AMPK). Thienopyridine analogs are being investigated for use as anti-inflammatory agents and cancer treatments.</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>2-(2-Hydroxyethyl)phenylboronic acid dehydrated is a molecule with a hydroxyl group, a neutral ph, and a hydroxyl group. It is used in the synthesis of nitro compounds and has shown to have an inhibitory effect on protein synthesis. The compound also binds to hyaluronic acid, which may be due to its structural similarity to the sugar glucose.</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

Versatile small molecule scaffold

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Pyrazolo[1,5-a]pyridin-4-ol is a heteroaromatic compound that acts as an inhibitor of phosphodiesterase (PDE). It prevents the breakdown of cyclic nucleotides and thus leads to increased levels of cAMP and cGMP. Pyrazolo[1,5-a]pyridin-4-ol has been shown to have bronchodilatory activity in animal models. The drug also inhibits the production of inflammatory mediators such as prostaglandins by inhibiting cyclooxygenases. In addition, pyrazolo[1,5-a]pyridin-4-ol has been shown to be a potential PDE inhibitor replacement for the more commonly used PDE inhibitors such as sildenafil and tadalafil. However, due to its lack of stereochemistry and its bicyclic chemical structure, pyrazolo[1,5-a]</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>3,8-Diethyl 4-aminopyrazolo[3,2-c][1,2,4]triazine-3,8-dicarboxylate is a structural formula that contains nitrogen atoms and a hydroxyl group. The alkylthio group and alkynyl groups are attached to the nitrogens on the 3 and 8 positions. This drug has been shown to be effective in treating chronic bronchitis, depression, and inflammatory diseases such as ischemia reperfusion injury. It also has a solid catalyst property which may be due to its ability to form complexes with dodecanedioic acid.</p>

<p>Versatile small molecule scaffold</p>

<p>Tert-butyl (2S)-2-aminohexanoate is an intermediate that is used in the synthesis of glycine by the reaction of benzyl bromide and tert-butyl amine. The stereospecifically incorporated tert-butyl group has a high degree of enantioselectivity, which makes this intermediate useful in the synthesis of glycine. Tert-butyl (2S)-2-aminohexanoate can be synthesized using lithium diisopropylamide and a tertiary amine as an alkylating agent.</p>

<p>Versatile small molecule scaffold</p>

<p>(5S)-5-(Propan-2-yl)pyrrolidin-2-one is a vinyl compound that is used in the production of polyvinyl acetate. It is produced by transesterification of vinyl acetate and ethylene oxide, followed by hydrolysis of the ester group. The reaction proceeds via an enzymatic process, which is initiated by lipases.br&gt;<br>(5S)-5-(Propan-2-yl)pyrrolidin-2-one can be converted to other compounds through a number of chemical reactions. For example, it can be oxidized to (5S)-5-(propane-2,3-dione)pyrrolidine with hydrogen peroxide or sodium hypochlorite. It also reacts with potassium permanganate to form (5S)-5-(propane-1,3 diol)pyrrolidine and manganese dioxide to form (5S</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>2-Oxononanoic acid is a fatty acid that inhibits the binding of diagnostic agents to interleukin receptors. 2-Oxononanoic acid has been shown to inhibit the production of reactive oxygen species, which may be due to its acidic pH. This compound also inhibits the release of inflammatory mediators, such as cytokines and arachidonic acid metabolites. 2-Oxononanoic acid has been shown to have therapeutic potential in autoimmune diseases and infectious diseases, such as HIV/AIDS. 2-Oxononanoic acid is an affinity ligand for fatty acids and can be used in conjugates with antibodies or antigens for diagnostic purposes or therapy.</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>